Share this page

Impacts and Economic Burden of Pompe Disease on Patients and Families in Thailand: A Mixed Method Study

Youngkong S; Thavorncharoensap M; Chaikledkaew U; Luangsinsiri C; Tim-Aroon T; Kuptanon C; Sathienkijkanchai A; Rojnueangnit K; Wichajarn K; Boonyawat B; Suphapeetiporn K; Wattanasirichaigoon D.
ClinicoEconomics and Outcomes Research 2026; 18():1-11 , 2026.

Prevalence of Severe Thalassemia and Performance of Prenatal Screening Tests Among Pregnant Women at Siriraj Thalassemia Center in Thailand

Malasai K, Chaikledkaew U, Talungchit P, Youngkong S, Udomsinprasert W, Limwongse C, Jittikoon J.
Clin Transl Sci 2026 Jan 3 , 2026.

A comparison of health-related quality of life between continuous ambulatory peritoneal dialysis and automated peritoneal dialysis in children with stage 5 chronic kidney disease in Thailand: a randomized controlled trial

Thavorncharoensap M, Chaikledkaew U, Youngkong S, Assanatham M, Wisanuyotin S, Chaiyapak T, Pongwilairat N, Srisuwan K, Bhummichitra P, Pruangprasert P, Boonyapapong P, Chongchet N, Khongkhanin U, Vachvanichsanong P, Chartapisak W, Pattaragarn A.
Pediatric Nephrology 2025 Jan 20 , 2025.

Association of NAT2 promoter hypermethylation with susceptibility to hepatotoxicity due to antituberculosis drugs and biomarker potential

Jittikoon J, Saengsiwaritt W, Chanhom N, Chaikledkaew U, Wattanapokayakit S, Mahasirimongkol S, Udomsinprasert W.
Scientific Reports 2025 Mar 25;15(1):10197 , 2025.

Cost effectiveness of bevacizumab plus carboplatin paclitaxel versus carboplatin paclitaxel as front line for advanced ovarian cancer in Thailand

Katanyoo K, Chaikledkaew U, Chandeying N.
Scientific Reports 2025 Mar 22;15(1):9949 , 2025.

Cost-Benefit Analysis of Genetic Testing as a Prenatal Diagnostic Tool for Thalassemia: A Single-Center Study From Central Thailand

Malasai K, Jittikoon J, Udomsinprasert W, Talungchit P, Youngkong S, Sangroongruangsri S, Mahasirimongkol S, Chaikledkaew U.
Clinicoecon Outcomes Res 2025 Feb 4;17:33-43 , 2025.

Cost-Effectiveness Analysis of Different Prenatal Screening Strategies for the Prevention of Severe Thalassemia in Thailand

Malasai K, Jittikoon J, Talungchit P, Youngkong S, Udomsinprasert W, Chaikledkaew U.
Clinicoecon Outcomes Res 2025 Nov 15;17:835-848 , 2025.

Cost-Utility Analysis of Metabolic Bariatric Surgery for Individuals with Obesity in Saudi Arabia

Nagi MA, Turongkaravee S, Almalki ZS, Thavorncharoensap M, Sangroongruangsri S, Chaikledkaew U, Alqahtani AM, AlSharif LS, Alsubaihi IA, Alzarea AI, Alsultan MM.
Clinicoecon Outcomes Res 2025 Jul 23;17:519-533 , 2025.

Determining health-related quality of life among children with malaria in Kenya: does the choice of EQ-5D value set matter?

Okech T, Thavorncharoensap M, Chaikledkaew U, Omondi GP, Nyokabi P, Thumbi SM, Thakkinstian A.
Health Qual Life Outcomes 2025 Nov 15;17:835-848 , 2025.

Economic Evaluation of Molecular Testing for Pulmonary Tuberculosis Diagnosis: A Systematic Review

Chitpim N, Yoopetch P, Jittikoon J, Udomsinprasert W, Bunwong K, Mahasirimongkol S, Chaikledkaew U.
Clinicoecon Outcomes Res 2025 Oct 1;17:661-671 , 2025.

Economic evaluation of automated peritoneal dialysis among pediatric patients with end state kidney diseases in Thailand

Assanatham M; Youngkong S; Thavorncharoensap M; Pattaragarn A; Chaikledkaew U.
Scientific Reports 2025 Mar 7 , 2025.

Economic evaluation of diagnostic tests for Thai patients with tuberculosis: A dynamic transmission model approach

Chitpim N; Praditsitthikorn N; White LJ; Meeyai A; Jittikoon J; Bunwong K; Youngkong S; Thavorncharoensap M; Mahasirimongkol S; Udomsinprasert W; Chaikledkaew U.
PLoS ONE 2025 Feb 19;73(7):4288-4298 , 2025.

Economic evaluation of dialysis treatment in end-stage renal disease patients with fluid and sodium overload: Evidence from a randomized controlled trial in Thailand

Youngkong S, Yoopetch P, Thavorncharoensap M, Assanatham M, Chaikledkaew U, Sritippayawan S.
PLoS One 2025 Nov 15;17:835-848 , 2025.

The Burden of Obesity in Saudi Arabia: A Real-World Cost-of-Illness Study

Nagi MA, Almalki ZS, Thavorncharoensap M, Sangroongruangsri S, Turongkaravee S, Chaikledkaew U, Alqahtani AM, AlSharif LS, Alsubaihi IA, Alzarea AI, Alsultan MM.
ClinicoEconomics and Outcomes Research 2025 Mar 21;17:233-246 , 2025.

What is the lifetime cost of alcohol consumption? an estimation of economic burden in Thailand

Luangsinsiri C; Thavorncharoensap M; Chaikledkaew U; Pattanaprateep O; Praditsitthikorn N; Sornpaisarn B; Rehm J.
PLoS ONE 2025 Apr-Jun;103(2):130-137 , 2025.

A systematic review and quality assessment of economic evaluations of kidney replacement therapies in end-stage kidney disease

Nyokabi P; Youngkong S; Bagepally BS; Okech T; Chaikledkaew U; McKay GJ; Attia J; Thakkinstian A.
Scientific Reports 2024; (23018):- , 2024.

Association between the CYP2B6 polymorphisms and nonnucleoside reverse transcriptase inhibitors drug-induced liver injury: a systematic review and meta-analysis

Chanhom N, Sonjan J, Inchai J, Udomsinprasert W, Chaikledkaew U, Suvichapanich S, Mahasirimongkol S, Jittikoon J.
Scientific Reports 2024 Nov 27;14(1):29511 , 2024.

Cartilage oligomeric matrix protein as a potential biomarker for knee osteoarthritis

Udomsinprasert W, Mookkhan N, Tabtimnark T, Aramruang T, Ungsudechachai T, Saengsiwaritt W, Jittikoon J, Chaikledkaew U, Honsawek S.
Bone Joint Res 2024 Jun 1;13(6):261-271 , 2024.

Catastrophic costs incurred by tuberculosis affected households from Thailand's first national tuberculosis patient cost survey

Youngkong S, Kamolwat P, Wongrot P, Thavorncharoensap M, Chaikledkaew U, Nateniyom S, Pungrassami P, Praditsitthikorn N, Mahasirimongkol S, Jittikoon J, Nishikiori N, Baena IG, Yamanaka T.
Sci Rep 2024 May 16;14(1):11205 , 2024.

Correction to: A systematic review and quality assessment of economic evaluations of kidney replacement therapies in end-stage kidney disease (Scientific Reports, (2024), 14, 1, (23018), 10.1038/s41598-024-73735-8)

Nyokabi P; Youngkong S; Bagepally BS; Okech T; Chaikledkaew U; McKay GJ; Attia J; Thakkinstian A.
Scientific Reports 2024 Oct 10;7(11):3334-3357 , 2024.

Cost Effectiveness of Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: A Systematic Review and Meta-analysis

Wattanasukchai L, Bubphan T, Thavorncharoensap M, Youngkong S, Chaikledkaew U, Thakkinstian A.
American Journal of Cardiovascular Drugs 2024 Nov 21 , 2024.

Cost-Utility and Budget Impact Analysis of Adding SGLT-2 Inhibitors to Standard Treatment in Type 2 Diabetes Patients with Heart Failure: Utilizing National Database Insights from Thailand

Kongmalai T, Prawjaeng J, Hadnorntun P, Leelahavarong P, Chaikledkaew U, Thakkinstian A, Srinonprasert V.
Pharmacoecon Open 2024; (e57):69-81 , 2024.

Cost-effective analysis of hepatitis A vaccination in Kerala state, India

Gurav YK, Bagepally BS, Chitpim N, Sobhonslidsuk A, Gupte MD, Chaikledkaew U, Thakkinstian A, Thavorncharoensap M.
PLoS One 2024 Jun 27;19(6):e0306293 , 2024.

Cost-utility analysis of home blood pressure measurement for screening and diagnosis of hypertension through village health volunteer mechanism in Thailand

Karnjanapiboonwong A, Chaikledkaew U, Anothaisintawee T, Praditsitthikorn N, Dejthevaporn C, Thakkinstian A.
PLoS One 2024 Oct 24;19(10):e0308851 , 2024.

Cost-utility and budget impact analysis of laparoscopic bariatric surgery for obesity with Type II Diabetes Mellitus in Thailand

Noparatayaporn P; Thavorncharoensap M; Chaikledkaew U; Looareesuwan P; Shantavasinkul PC; Sumritpradit P; Thakkinstian A.
PLoS ONE 2024 Nov 8;7(12):3795-3803 , 2024.

Cost-utility and budget impact analysis of neoadjuvant dual HER2 targeted therapy for HER2-positive breast cancer in Sri Lanka

Gunasekara ADM; Youngkong S; Anothaisintawee T; Dejthevaporn T; Fernandopulle R; Chaikledkaew U.
Scientific Reports 2024 Jun 28;83:56-65 , 2024.

Economic evaluation of diagnosis and treatment for latent tuberculosis infection among contacts of pulmonary tuberculosis patients in Thailand

Yoopetch P; Wu O; Jittikoon J; Thavorncharoensap M; Youngkong S; Praditsitthikorn N; Mahasirimongkol S; Anothaisintawee T; Udomsinprasert W; Chaikledkaew U.
Scientific Reports 2024 May 28;15(7):2483-2495 , 2024.

Economic evaluation of tenofovir disoproxil fumarate prophylaxis to prevent mother-to-child transmission of Hepatitis B virus infection: evidence from a lower-middle income country

Nguyen HT; Chaikledkaew U; Hoang MV; Tran VQ; Thavorncharoensap M; Praditsitthikorn N; Tran QD; Thakkinstian A.
BMC Health Services Research 2024 Nov 8;7(12):3795-3803 , 2024.

Lifetime costs of alcohol consumption in Thailand: protocol for an incidence-based cost-of-illness study using Markov model

Luangsinsiri C, Thavorncharoensap M, Chaikledkaew U, Pattanaprateep O, Sornpaisarn B, Rehm J.
BMJ Open 2024 Apr 29;14(4):e079829 , 2024.

Outcomes associated with postoperative cognitive dysfunction: a systematic review and meta-analysis

Suraarunsumrit P, Srinonprasert V, Kongmalai T, Suratewat S, Chaikledkaew U, Rattanasiri S, McKay G, Attia J, Thakkinstian A.
Age Ageing 2024 Jul 2;53(7):afae160 , 2024.

Projected Cost Savings With Optimal Medication Adherence in Patients With Cardiovascular Disease Requiring Lipid-Lowering Therapy: A Multinational Economic Evaluation Study

Cho JY, Wilson FA, Chaikledkaew U, Chen Y, Phrommintikul A, Diaz-Aguilera MA, Chen Z, Kim K, Chaiyakunapruk N.
Journal of the American Heart Association 2024 Nov 19;13(22):e037792 , 2024.

Economic analysis of pharmacogenetics testing for human leukocyte antigen-based adverse drug reactions

Yuliwulandari R, Chaikledkaew U, Prayuni K, Zahroh H, Mahasirimongkol S, Turongkaravee S, Jittikoon J, Wattanapokayakit S, Patrinos G.P.
Economic Evaluation in Genomic and Precision Medicine , 2023.

Economic cost of patients with trisomy 13, 18, and 21 in a tertiary hospital in Thailand

Wongkrajang P; Jittikoon J; Udomsinprasert W; Talungchit P; Chaikledkaew U.
PloS one 2023 Nov 16;18(11):e0291918 , 2023.

Economic costs of alcohol consumption in Thailand, 2021

Luangsinsiri C; Youngkong S; Chaikledkaew U; Pattanaprateep O; Thavorncharoensap M.
Global Health Research and Policy 2023; 8(51):- , 2023.

Economic costs of obesity: a systematic review

Nagi MA, Ahmed H, Rezq MAA, Sangroongruangsri S, Chaikledkaew U, Almalki Z, Thavorncharoensap M.
Int J Obes (Lond) 2023 Oct 26 , 2023.

Economic evaluation of prenatal screening for fetal aneuploidies in Thailand

Wongkrajang P; Jittikoon J; Udomsinprasert W; Talungchit P; Sangroongruangsri S; Turongkaravee S; Chaikledkaew U.
PLoS ONE 2023 Feb;89(2):843-852 , 2023.

Effect of vitamin D supplementation on circulating level of autophagosome protein LC3A, inflammation, and physical performance in knee osteoarthritis

Saengsiwaritt W, Jittikoon J, Chaikledkaew U, Tawonsawatruk T, Honsawek S, Udomsinprasert W.
Clin Transl Sci 2023 Sep 25 , 2023.

Efficacy and safety of monoclonal antibody therapy in patients with neuromyelitis optica spectrum disorder: A systematic review and network meta-analysis

Aungsumart S, Youngkong S, Dejthevaporn C, Chaikledkaew U, Thadanipon K, Tansawet A, Khieukhajee J, Attia J, McKay G.J, Thakkinstian A.
Frontiers in Neurology , 2023.

Efficacy of anti-tuberculosis drugs for the treatment of latent tuberculosis infection: a systematic review and network meta-analysis

Yoopetch P, Anothaisintawee T, Gunasekara ADM, Jittikoon J, Udomsinprasert W, Thavorncharoensap M, Youngkong S, Thakkinstian A, Chaikledkaew U.
Sci Rep 2023 Sep 27;13(1):16240 , 2023.

Host genetic polymorphisms involved in long-term symptoms of COVID-19

Udomsinprasert W; Nontawong N; Saengsiwaritt W; Panthan B; Jiaranai P; Thongchompoo N; Santon S; Runcharoen C; Sensorn I; Jittikoon J; Chaikledkaew U; Chantratita W.
Emerging Microbes and Infections 2023 Sep;29(3):479-503 , 2023.

Prenatal screening tests and prevalence of fetal aneuploidies in a tertiary hospital in Thailand

Wongkrajang P, Jittikoon J, Sangroongruangsri S, Talungchit P, Ruangvutilert P, Panchalee T, Chaikledkaew U.
PLoS One , 2023.

Prenatal screening tests and prevalence of fetal aneuploidies in a tertiary hospital in Thailand

Wongkrajang P; Jittikoon J; Sangroongruangsri S; Talungchit P; Ruangvutilert P; Panchalee T; Chaikledkaew U.
PLoS ONE 2023; 18(e0284829):- , 2023.

Rituximab for the treatment of relapsing-remitting multiple sclerosis in Thailand: an economic evaluation and budget impact analysis

Aungsumart S; Turongkaravee S; Youngkong S; Apiwattanakul M; Thakkinstian A; Chaikledkaew U.
BMC Health Services Research 2023 Nov 16;18(11):e0293866 , 2023.

Systematic review of the impact of health care expenditure on health outcome measures: implications for cost-effectiveness thresholds

Gloria MAJ, Thavorncharoensap M, Chaikledkaew U, Youngkong S, Thakkinstian A, Chaiyakunapruk N, Ochalek J, Culyer AJ.
Expert Rev Pharmacoecon Outcomes Res 2023 Dec 19:1-13 , 2023.

A comparison of six approaches for measuring utility values among patients with locally advanced cervical cancer

Katanyoo K, Thavorncharoensap M, Chaikledkaew U, Riewpaiboon A.
Expert Review of Pharmacoeconomics and Outcomes Research 2022 Jan;22(1):107-117 , 2022.

Comparative efficacy and safety of pharmacologic interventions to prevent mother-to-child transmissionย of hepatitis B virus: a systematic reviewย and network meta-analysis

Nguyen HT, Thavorncharoensap M, Phung TL, Anothaisintawee T, Chaikledkaew U, Sobhonslidsuk A, Talungchit P, Chaiyakunapruk N, Attia J, McKay GJ, Thakkinstian A.
Am J Obstet Gynecol 2022 Aug;227(2):163-172 , 2022.

Cost-Utility Analysis of Molecular Testing for Tuberculosis Diagnosis in Suspected Pulmonary Tuberculosis in Thailand

Chitpim N, Jittikoon J, Udomsinprasert W, Mahasirimongkol S, Chaikledkaew U.
ClinicoEconomics and Outcomes Research 2022 Feb 2;14:61-73 , 2022.

Economic Evaluation of Multiple-Pharmacogenes Testing for the Prevention of Adverse Drug Reactions in People Living with HIV

Turongkaravee S, Praditsitthikorn N, Ngamprasertchai T, Jittikoon J, Mahasirimongkol S, Sukasem C, Udomsinprasert W, Wu O, Chaikledkaew U.
Clinicoecon Outcomes Res 2022 Jul 7;14:447-463 , 2022.

Economic Evaluation of Screening Strategy for Latent Tuberculosis Infection (LTBI) in Contacts of Tuberculosis Patients: Systematic Review and Quality Assessment

Yoopetch P, Chitpim N, Jittikoon J, Udomsinprasert W, Thavorncharoensap M, Youngkong S, Praditsitthikorn N, Mahasirimongkol S, Chaikledkaew U.
International Journal of Environmental Research and Public Health 2022 May;43(9-10):939-954 , 2022.

Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis

Noviyani R, Youngkong S, Nathisuwan S, Bagepally BS, Chaikledkaew U, Chaiyakunapruk N, McKay G, Sritara P, Attia J, Thakkinstian A.
BMJ Evid Based Med 2022 Aug;27(4):215-223 , 2022.

Genetic polymorphisms of ACE1, ACE2, and TMPRSS2 associated with COVID-19 severity: A systematic review with meta-analysis

Saengsiwaritt W, Jittikoon J, Chaikledkaew U, Udomsinprasert W.
Rev Med Virol 2022 Apr;31(4):1267-1268 , 2022.

Incremental net monetary benefit of direct oral anticoagulants for the prevention of venous thromboembolism after total knee or hip replacement: A systematic review and meta-analysis

Veettil SK, Harris J, Syeed MS, Thakkinstian A, Chaikledkaew U, Witt DM, Chaiyakunapruk N.
Thromb Res 2022 Aug;216:74-83 , 2022.

Meta-analysis of economic evaluation studies: data harmonisation and methodological issues

Bagepally BS, Chaikledkaew U, Chaiyakunapruk N, Attia J, Thakkinstian A.
BMC Health Services Research 2022 May;43(9-10):939-954 , 2022.

Mitochondrial DNA content as a diagnostic marker for antituberculosis drug-induced liver injury

Udomsinprasert W, Jittikoon J, Chaikledkaew U, Saengsiwaritt W, Chanhom N, Suvichapanich S, Wattanapokayakit S, Mahasirimongkol S, Chantratita W.
Int J Infect Dis 2022 Sep;122:1034-1040 , 2022.

The Association of HLA-B*35 and GSTT1 Genotypes and Hepatotoxicity in Thai People Living with HIV

Chanhom N, Jittikoon J, Wattanapokayakit S, Mahasirimongkol S, Charoenyingwattana A, Udomsinprasert W, Chaikledkaew U, Suvichapanich S, Mushiroda T, Kiertiburanakul S, Rojanawiwat A, Wangsomboonsiri W, Manosuthi W, Kantipong P, Apisarnthanarak A, Sangsirinakakul W, Wongprasit P, Chaiwarith R, Tantisiriwat W, Sungkanuparph S, Chantratita W.
J Pers Med 2022;71(7):1085-1096 , 2022.

A systematic review and meta-analysis of genotype-based and individualized data analysis of SLCO1B1 gene and statin-induced myopathy

Turongkaravee S, Jittikoon J*, Lukkunaprasit T, Sangroongruangsri S, Chaikledkaew U, Thakkinstian A..
Pharmacogenomics J 2021; 21(3): 296-307., 2021.

A systematic review of demand-side methods of estimating the societal monetary value of health gain

Gloria MAJ, Thavorncharoensap M*, Chaikledkaew U, Youngkong S, Thakkinstian A, Culyer AJ..
Value in Health 2021; 24(10): 1423-1434., 2021.

CYP2E1, GSTM1, and GSTT1 genetic polymorphisms and their associations with susceptibility to antituberculosis drug-induced liver injury in Thai tuberculosis patients

Chanhom N, Wattanapokayakit S, Satproedprai N, Suvichapanich S, Mahasirimongkol S, Chaikledkaew U, Udomsinprasert W, Mushiroda T, Jittikoon J*..
Heliyon 2021; 7(4): e06852., 2021.

Cartilage oligomeric matrix protein as a marker of progressive liver fibrosis in biliary atresia

Udomsinprasert W*, Angkathunyakul N, Jittikoon J, Chaikledkaew U, Vejchapipat P, Poovorawan Y, Honsawek S..
Scientific Reports 2021; 11(1): 16695., 2021.

Cellular senescence in liver fibrosis: Implications for age-related chronic liver diseases

Udomsinprasert W*, Sobhonslidsuk A, Jittikoon J, Honsawek S, Chaikledkaew U..
Expert Opinion on Therapeutic Targets 2021; 25(9): 799-813., 2021.

Circulating levels of interleukin-6 and interleukin-10, but not tumor necrosis factor-alpha, as potential biomarkers of severity and mortality for COVID-19: systematic review with meta-analysis

Udomsinprasert W*, Jittikoon J, Sangroongruangsri S, Chaikledkaew U..
Journal of clinical immunology 2021; 41(1): 11-22., 2021.

Cost-effectiveness analysis of diagnostic tests for para-aortic lymph node detection in locally advanced cervical cancer

Katanyoo K, Chaikledkaew U*, Thavorncharoensap M, Riewpaiboon A..
Clinicoecon Outcomes Res 2021; 13: 943-955., 2021.

Cost-utility analysis of dapagliflozin compared to sulfonylureas for type 2 diabetes as second-line treatment in indian healthcare payer’s perspective

Bagepally BS, Chaikledkaew U*, Youngkong S, Anothaisintawee T, Thavorncharoensap M, Dejthevaporn C, Thakkinstian A..
ClinicoEconomics and Outcomes Research 2021; 13: 897-907., 2021.

Cost-utility analysis of drug treatments in patients with polypoidal choroidal vasculopathy in Thailand

Sangroongruangsri S, Chaikledkaew U*, Hanusaha P, Ratanapakorn T, Ruamviboonsuk P..
ClinicoEconomics and Outcomes Research 2021; 13: 917-926., 2021.

Cost-utility analysis of vasoconstrictors plus albumin in the treatment of thai patients with type 1 hepatorenal syndrome

Sangroongruangsri S, Kittrongsiri K, Charatcharoenwitthaya P, Sobhonslidsuk A, Chaikledkaew U*..
ClinicoEconomics and Outcomes Research 2021; 13: 703-715., 2021.

Economic evaluation of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer: systematic review and quality assessment

Genuino AJ, Gloria MAJ, Chaikledkaew U*, Reungwetwattana T, Thakkinstian A..
Expert Review of Pharmacoeconomics and Outcomes Research 2021; 21(5): 1001-1010., 2021.

Economic evaluation of population-based type 2 diabetes mellitus screening at different healthcare settings in Vietnam

Toi PL, Wu O, Thavorncharoensap M, Srinonprasert V, Anothaisintawee T, Thakkinstian A, Phuong NK, Chaikledkaew U*..
PLoS One 2021; 16(12): e0261231., 2021.

Global DNA hypomethylation of Alu and LINE-1 transposable elements as an epigenetic biomarker of anti-tuberculosis drug-induced liver injury

Udomsinprasert W*, Sakuntasri W, Jittikoon J, Chaikledkaew U, Honsawek S, Chantratita W, Wattanapokayakit S, Mahasirimongkol S..
Emerging Microbes and Infections 2021; 10(1): 1862-1872., 2021.

Incremental net monetary benefit of bariatric surgery: Systematic review and meta-analysis of cost-effectiveness evidences

Noparatayaporn P, Thavorncharoensap M*, Chaikledkaew U, Bagepally BS, Thakkinstian A..
Obesity Surgery 2021; 31(7): 3279-3290., 2021.

Pharmacogenetic testing for adverse drug reaction prevention: systematic review of economic evaluations and the appraisal of quality matters for clinical practice and implementation

Turongkaravee S, Jittikoon J, Rochanathimoke O, Boyd K, Wu O, Chaikledkaew U*..
BMC Health Services Research 2021; 21(1): 1042., 2021.

The Cost of locally advanced cervical cancer in Thailand: An empirical study for economic analysis

Katanyoo K, Riewpaiboon A*, Chaikledkaew U, Thavorncharoensap M..
Asian Pacific Journal of Cancer Prevention 2021; 22(10): 3171-3179., 2021.

Decreased circulating vitamin D reflects adverse outcomes of hepatitis C virus infection: A systematic review and meta-analysis

Udomsinprasert W*, Jittikoon J, Sukkho S, Pojarassangkul N, Sangroongruangsri S, Chaikledkaew U..
Journal of infection 2020; 81(4): 585-599., 2020.

Diagnostic performance of clinic and home blood pressure measurements compared with ambulatory blood pressure: a systematic review and meta-analysis

Karnjanapiboonwong A, Anothaisintawee T*, Chaikledkaew U, Dejthevaporn C, Attia J, Thakkinstian A..
BMC Cardiovascular Disorders 2020; 20(1):491., 2020.

Economic evaluation of carbetocin as prophylaxis for postpartum hemorrhage in the Philippines

Briones JR, Talungchit P, Thavorncharoensap M, Chaikledkaew U*..
BMC health services research 2020; 20(1): 975., 2020.

Economic impact of medical genetic testing on clinical applications in Thailand

Jittikoon J, Sangroongruangsri S, Thavorncharoensap M, Chitpim N, Chaikledkaew U*..
PLoS one 2020; 15(12): e0243934., 2020.

GSTM1 and GSTT1 genetic polymorphisms and their association with antituberculosis drug-induced liver injury

Chanhom N, Udomsinprasert W, Chaikledkaew U, Mahasirimongkol S, Wattanapokayakit S, Jittikoon J*..
Biomedical reports 2020; 12(4): 153-162., 2020.

Glucagon-like peptide 1 agonists for treatment of patients with type 2 diabetes who fail metformin monotherapy: Systematic review and meta-analysis of economic evaluation studies

Bagepally BS, Chaikledkaew U*, Gurav YK, Anothaisintawee T, Youngkong S, Chaiyakunapruk N, McEvoy M, Attia J, Thakkinstian A..
BMJ open diabetes res care 2020; 8(1): e001020., 2020.

Preventive role of diet interventions and dietary factors in type 2 diabetes mellitus: An umbrella review

Toi PL, Anothaisintawee T*, Chaikledkaew U, Briones JR, Reutrakul S, Thakkinstian A..
Nutrients 2020; 12(9): 2722: 1-17., 2020.

Quality assessment and cost saving of renal dosing recommendation by clinical pharmacists at medical wards in Thailand

Sukkha S, Rattanavipanon W, Chamroenwit B, Sanganurak M, Nathisuwan S, Chaikledkaew U, Kongwatcharapong J*..
International journal of clinical pharmacy 2020; 42(2): 610-616., 2020.

Survival analysis of colorectal cancer patients in a Thai hospital-based cancer registry

Kittrongsiri K, Wanichsuwan W, Prechawittayakul P, Sangroongruangsri S, Cairns J, Chaikledkaew U*..
Expert Review of gastroenterology & hepatology 2020; 14(4): 291-300., 2020.

A real-world study of effectiveness of intravitreal bevacizumab and ranibizumab injection for treating retinal diseases in Thailand

Kumluang S, Ingsrisawang L*, Sangroongruangsri S, Chaikledkaew U, Ratanapakorn T, Ruamviboonsuk P, Taweebanjongsin W, Choovuthayakorn J, Thoongsuwan S, Hanutsaha P, Kulvichit K, Ratanapojnard T, Wongsawad W, Leelahavarong P, Teerawattananon Y..
BMC Ophthalmology 2019; 19(1); 82., 2019.

Adjuvant trastuzumab regimen for HER2-positive early-stage breast cancer: a systematic review and meta-analysis

Genuino AJ, Chaikledkaew U*, The DO, Reungwetwattana T, Thakkinstian A..
Expert Review of Clinical Pharmacology 2019; 12(8); 815-824., 2019.

Burden of Diseases among Nursing Staff in a Tertiary Hospital in Thailand

Lertpitakpong C,Sriratanaban J, Chaikledkaew U, Hanvoravongchai P..
PACIFIC RIM INTERNATIONAL JOURNAL OF NURSING RESEARCH 2019;23(2):180-193, 2019.

Cost-effectiveness modelling studies of all preventive measures against rabies: A systematic review

Anothaisintawee T, Julienne Genuino A, Thavorncharoensap M, Youngkong S, Rattanavipapong W, Meeyai A, Chaikledkaew U*..
Vaccine 2019; 37: A146-A153., 2019.

Publication Preview Source Southeast Asian Pharmacogenomics Research Network (SEAPharm): Current Status and Perspectives

Chumnumwat S, Lu Z, H, Sukasem C, Winther M, D, Capule F, R, Abdul Hamid A, A, Bhandari B, Chaikledkaew U, Chanhom N, Chantarangsu S, Charoenyingwattana A, Hang T, T, Hlaing T, M, Htun K, S, Jittikoon J, Le L, Mahasirimongkol S, Mohamed Noor D, A, Sh.
Public Health Genomics, 2019.

Real-world safety of intravitreal bevacizumab and ranibizumab treatments for retinal diseases in Thailand: A prospective observational study

Sangroongruangsri S, Chaikledkaew U*, Kumluang S, Wu O, Geue C  , Ratanapakorn T, Leelahavarong P, Ingsrisawang L, Ruamviboonsuk P, Taweebanjongsin W, Choovuthayakorn.
Clinical Drug Investigation 2019; 39(1): 115-115., 2019.

Revisit roles of HTA on drug policy in universal health coverage in Thailand: Where are we? and what is next?

Tanvejsilp P, Taychakhoonavudh S, Chaikledkaew U, Chaiyakunapruk N, Ngorsuraches S*..
Value in Health Regional Issues 2019; 18: 78-82., 2019.

Systematic review and meta-analysis of cost-effectiveness of rotavirus vaccine in low-income and lower-middle-income countries

Haider S, Chaikledkaew U*, Thavorncharoensap M, Youngkong S, Islam MA, Thakkinstian A ..
Open Forum Infectious Diseases 2019; 6(4); ofz117., 2019.

The impact of transmission dynamics of rabies control: Systematic review

Rattanavipapong W, Thavorncharoensap M, Youngkong S, Genuino AJ, Anothaisintawee T, Chaikledkaew U, Meeyai A*..
Vaccine 2019; A154-A165., 2019.

Treatment cost and costing model of obstetric complications at a hospital in Myanmar

Thi Win Shwe A, Riewpaiboon A*, Chaikledkaew U, Youngkong S..
PLoS ONE 2019;14(3):e0213141, 2019.

Comparative efficacy of bevacizumab, ranibizumab, and aflibercept for treatment of macular edema secondary to retinal vein occlusion: a systematic review and network meta-analysis

Sangroongruangsri S., Ratanapakorn T., Wu O., Anothaisintawee T., Chaikledkaew U..
Expert Review of Clinical Pharmacology 2018; 11(9): 903-916., 2018.

Development of Relative Value Units for Unit Cost analysis of Medical Services in Vietnam

Vo T.Q., Chaikledkaew U., Van Hoang M., Nguyen H.T., Riewpaiboon A..
Asian Journal of Pharmaceutics 2018; 12(1): s19-s26, 2018.

Economic burden of multidrug-resistant tuberculosis: a multicenter study across Vietnamese regions

Nam V.X., Nhung N.V., Hoa N.B., Thuy H.T.T., Phuong N.T.M., Anh N.T., Ngoc Anh L.T., Trung V.Q., Ha T.V., Meeyai A., Thavorncharoensap M., Chaikledkaew U..
International Journal of Tuberculosis and Lung Disease 2018; 22(8): 912-917., 2018.

Economic costs of alcohol use in Sri Lanka

Ranaweera S, Amarasinghe H, Chandraratne N*, Thavorncharoensap M., Ranasinghe T, Karunaratna S, Kumara D, Santatiwongchai B, Chaikledkaew U, Abeykoon P, De Silva A..
PLoS ONE 2018; 13(6): Art.no.e0198640, 2018.

Health utilities of patients with multiple sclerosis and neuromyelitis optica spectrum disorders in Thailand

Siritho S., Thavorncharoensap M., Chanatittarat C., Pasogpakdee P., Apiwattanakul M., Prayoonwiwat N., Chankrachang S., Riewpaiboon A., Chaikledkaew U..
Multiple Sclerosis and Related Disorders 2018; 24: 151-156., 2018.

Hospital cost analysis in developing countries: A methodological comparison in Vietnam

Vo T.Q., Chaikledkaew U., Van Hoang M., Nguyen H.T., Riewpaiboon A..
Asian Journal of Pharmaceutics 2018; 12(1): S8-S18., 2018.

Influenza vaccination in acute coronary syndromes patients in Thailand: The cost-effectiveness analysis of the prevention for cardiovascular events and pneumonia

Sribhutorn A., Phrommintikul A., Wongcharoen W., Chaikledkaew U., Eakanunkul S., Sukonthasarn A..
Journal of Geriatric Cardiology 2018; 15(6): 413-421., 2018.

Modelling the health economic impact of influenza vaccination strategies for high-risk children in Vietnam

Vo T.Q., Chaikledkaew U., Van Hoang M., Riewpaiboon A..
Journal of Clinical and Diagnostic Research 2018; 12(6): LC26-LC32., 2018.

NAT2 ultra-slow acetylator and risk of anti-tuberculosis drug-induced liver injury: A genotype-based meta-analysis

Suvichapanich S, Fukunaga K, Zahroh H, Mushiroda T, Mahasirimongkol S*, Toyo-Oka L, Chaikledkaew U, Jittikoon J, Yuliwulandari R, Yanai H, Wattanapokayakit S, Tokunaga K..
Pharmacogenetics and Genomics 2018; 28(7): 167-176, 2018.

Prognostic indicators for heart failure hospitalization in acute coronary syndrome patients: An observational study under the influenza vaccination trial

Sribhutorn A., Phrommintikul A., Wongcharoen W., Chaikledkaew U., Eakanunkul S., Patumanond J., Sukonthasarn A..
Journal of the Medical Association of Thailand 2018; 101(8): 1043-1049, 2018.

Real-World safety of intravitreal bevacizumab and ranibizumab treatments for retinal diseases in Thailand: A prospective observational study

Sangroongruangsri S, Chaikledkaew U*, Kumluang S, Wu O, Geue C, Ratanapakorn T, Leelahavarong P, Ingsrisawang L, Ruamviboonsuk P, Taweebanjongsin W, Choovuthayakorn J, Singalavanija A, Hanutsaha P.
Clinical Drug Investigation 2018; 38(9): 853-865, 2018.

Cost of Acute Care For Ischemic Stroke in Thailand

Sribundit N*, Riewpaiboon A, Chaikledkaew U, Stewart JF, Tantirittisak T, Hanchaipiboolkul S..
Southeast Asian Journal of Tropical Medicine and Public Health 2017; 48(3): 628-640., 2017.

Economic burden of influenza at a tertiary hospital in Vietnam

Vo TQ, Chaikledkaew U, Hoang MV, Riewpaiboon A.*.
Asian Pacific Journal of Tropical Disease 2017; 7(3): 144-150, 2017.

Social and economic burden of patients with influenza-like illness and clinically diagnosed flu treated at various health facilities in Vietnam

Quang Vo T, Chaikledkaew U, van Hoang M, Riewpaiboon A*..
ClinicoEconomics and Outcomes Research 2017; 9: 423-432, 2017.

Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations

Jittikoon J, Mahasirimongkol S, Charoenyingwattana A, Chaikledkaew U, Tragulpiankit P, Mangmool S, Inunchot W, Somboonyosdes C, Wichukchinda N, Sawanpanyalert P, He Y.f, Mcleod H.L.f, Chantratita W*..
Journal of Human Genetics. 2016; 61(2): 119-127., 2016.

Cost-utility and budget impact analysis of drug treatments in pulmonary arterial hypertension associated with congenital heart diseases in Thailand

Thongsri W, Bussabawalai T, Leelahavarong P, Wanitkun S, Durongpisitkul K, Chaikledkaew U*, Teerawattananon Y..
Expert Review of Pharmacoeconomics and Outcomes Research 2016; 16(4): 525-536., 2016.

Healthcare costing studies in developing countries: A systematic review in Vietnam

Vo TQ, Chaikledkaew U, Van Hoang M, Riewpaiboon A*..
International Journal of Pharmaceutical Sciences Review and Research 2016; 39(2): 295-299., 2016.

Nationwide survey of nutritional management in an Asian upper-middle income developing country government hospitals: Combination of quantitative survey and focus group discussion

Chittawatanarat K, Tosanguan K, Chaikledkaew U, Tejavanija S, Teerawattananon Y..
Clinical Nutrition ESPEN 2016; 14: 24-30, 2016.

The Modification Effect of Influenza Vaccine on Prognostic Indicators for Cardiovascular Events after Acute Coronary Syndrome: Observations from an Influenza Vaccination Trial

Sribhutorn A, Phrommintikul A*, Wongcharoen W, Chaikledkaew U, Eakanunkul S, Sukonthasarn A..
Cardiology Research and Practice 2016; 2016:4097471., 2016.

Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations.

Jittikoon J, Mahasirimongkol S, Charoenyingwattana A, Chaikledkaew U, Tragulpiankit P, Mangmool S, Inunchot W, Somboonyosdes C, Wichukchinda N, Sawanpanyalert P, He Y, McLeod HL, Chantratita W*..
Journal of Human Genetics 2015; 1-9, 2015.

Cost-utility analysis of adjuvant chemotherapy in patients with stage III colon cancer in Thailand

Lerdkiattikorn P, Chaikledkaew U, Lausoontornsiri W, Chindavijak S, Khuhaprema, T, Tantai N, Teerawattananon Y..
Expert Review of Pharmacoeconomics and Outcomes Research 2015; 15(4): 687-700, 2015.

Cost-utility and budget impact analysis of drug treatments in pulmonary arterial hypertension associated with congenital heart diseases in Thailand

Thongsri W, Bussabawalai T, Leelahavarong P, Wanitkun S, Durongpisitkul K, Chaikledkaew U*, Teerawattananon Y..
Expert Review of Pharmacoeconomics and Outcomes Research 2015; 1-12, 2015.

Prevalence of Idiopathic Inflammatory Demyelinating Central Nervous System Disorder in Thailand

Prayoonwiwat N, Apiwattanakul M, Pasogpakdee P, Siritho S, Chanatittarat C, Chaikledkaew U..
Multiple sclerosis journal. 2015; 21(6): 824-824., 2015.

The Quality of Life in Thai Patients with Neuromyelitis Optica Spectrum Disorders

Siritho S, Pasogpakdee P, Apiwattanakul M, Prayoonwiwat N, Chankrachang S, Chanatittarat C, Chaikledkaew U..
Multiple sclerosis journal 2015; 21(6): 825-826, 2015.

A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand

Tantai N, Chaikledkaew U*, Tanwandee T, Werayingyong P, Teerawattananon Y..
BMC Health Services Research 2014; 14(1), 2014.

Adverse Drug Event of Hospitalized Patients from Multi-Hospitals in Thailand

Tragulpiankit P, Yeesoonpan N, Ninsananda T, Chindavijak B, Chulavatnatol S, Chaikledkaew U, Uaviseswong T..
Pharmacoepidemiology and drug safety 2014; 23: 289-289, 2014.

Economic Evaluation of Colorectal Cancer Screening: A Systematic Review

Kittrongsiri K, Chaikledkaew U*..
Mahidol University Journal of Pharmaceutical Sciences 2014; 41 (2), 31-38, 2014.

Economic evaluation and budget impact analysis of the surveillance program for hepatocellular carcinoma in thai chronic hepatitis B patients

Sangmala P, Chaikledkaew U*, Tanwandee T, Pongchareonsuk P..
Asian Pacific Journal of Cancer Prevention 2014; 15(20): 8993-9004, 2014.

Guidelines for health technology assessment in Thailand (second edition)--the development process.

Chaikledkaew U, Kittrongsiri K..
J Med Assoc Thai. 2014; 97(5) :54-59., 2014.

Knowledge, acceptance, and willingness to pay for human papilloma virus (HPV) vaccination among female parents in Thailand

Kruiroongroj S, Chaikledkaew U, Thavorncharoensap M*..
Asian Pacific Journal of Cancer Prevention 2014; 15(13): 5469-5474, 2014.

Presentation of economic evaluation results.

Chaikledkaew U*..
Journal of the Medical Association of Thailand 2014; 97(5): s72-s80, 2014.

Quality assessment of health economic evaluation.

Chaikledkaew U, Kittrongsiri K..
J Med Assoc Thai. 2014; 97(5) :S113-8., 2014.

Safety of Intravitreal Bevacizumab Injection for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Systematic Review

Sangroongruangsri S, Chaikledkaew U*..
Mahidol University Journal of Pharmaceutical Sciences 2014; 41 (3): 23-30., 2014.

Advanced health biotechnologies in Thailand: Redefining policy directions

Velasco R.P*, Chaikledkaew U, Myint CY, Khampang R, Tantivess S, Teerawattananon Y..
Journal of Translational Medicine 2013; 11(1), 2013.

Efficacy of Varenicline and Nortriptyline in Smoking Cessation: Indirect Comparison of Randomized Controlled Trials

Khairod P, Apichartkulchai S, Chaikledkaew U, Thavorncharoensap M*.
Mahidol University Journal of Pharmaceutical Sciences 2013; 40 (4), 31-39, 2013.

Systematic Review of Economic Evaluation of Drug Treatments in Pulmonary Arterial Hypertension (PAH)

Thongsri W, Chaikledkaew U*, Teerawattananon Y..
Mahidol University Journal of Pharmaceutical Sciences 2013; 40(2): 45-50., 2013.

Clinical Efficacy of Chronic Hepatitis B Treatment for Patients with HBeAg-Positive Indirect Comparison: Indirect Comparison Meta-Analysis

Tantai N, Lerdkiattikorn P, Chaikledkaew U*, Tanwandee T, Weerayingyong P, Teerawattananon Y..
Mahidol University Journal of Pharmaceutical Sciences 2012; 39(2): 37-40, 2012.

Quality of Life among Stage III Colon Cancer Patients Receiving Oral and Intravenous Chemotherapy Reimens in Thailand.

Lerdkiattikorn P, Tantai N, Chaikledkaew U*, Lausoontornsiri W, Khuhaprema T, Kingkaew P, Teerawattananon Y..
Mahidol University Journal of Pharmaceutical Sciences 2012; 39(2): 50-52, 2012.

Systematic Review of Economic Evaluation of Pharmacist Intervention Related to Adverse Drug Event Prevention among Patients with Hospitalization.

Uaviseswong T, Chaikledkaew U*, Tragulpiankit P..
Mahidol University Journal of Pharmaceutical Sciences 2012; 39(1): 38-43., 2012.

Systematic Review of Economic Evaluation of The Surveillance Programs for Hepatocellular Carcinoma (HCC) in Chronic Hepatitis B Patients.

Sangmala P, Chaikledkaew U*, Tanwandee T..
Mahidol University Journal of Pharmaceutical Sciences 2012; 39(1): 33-37., 2012.

Systematic Review of Economic Evaluation of the First Line Treatment for Metastasis Renal Cell Carcinomo (mRCC).

Chanatittarat C, Chaikledkaew U*..
Mahidol University Journal of Pharmaceutical Sciences 2012; 39(3-4): 39-42., 2012.

การเข้าถึงและปัจจัยที่มีผลต่อการเข้าถึงการผ่าตัดต้อ

กัลยา ตีระวัฒนานนท์, รักมณี บุตรชน, ขวัญใจ วงศ์กิตติรักษ์, ชนิดา เลิศพิทักษ์พงศ์, ธีระ ศิริสมุด, อุษา ฉายเกล็ดแก้ว, ยศ ตีระวัฒนานนท์.
วารสารวิชาการสาธารณสุข. 2011; 20:SI53-SI68, 2011.

ความคุ้มค่าของการผ่าตัดต้อกระจกโดยใส่เลนส์แก้วตาเทียมชนิดนิ่มเปรียบเทียบกับชนิดแข็งในบริบทของประเทศไทย

กัลยา ตีระวัฒนานนท์, ขวัญใจ วงศ์กิตติรักษ์, รักมณี บุตรชน, ปฤษพร กิ่งแก้ว,อุษา ฉายเกล็ดแก้ว, ยศ ตีระวัฒนานนท์.
วารสารวิชาการสาธารณสุข 2554; 20(2): 235-250, 2011.

ทบทวนการดำเนินการลดการบริโภคเครื่องดื่มแอลกอฮอล์ในประเทศไทย พ.ศ.2540-2550

จอมขวัญ โยธาสมุทร, ศิตาพร ยังคง, ยศ ตีระวัฒนานนท์, มนทรัตม์ ถาวรเจริญทรัพย์, ศรีเพ็ญ ตันติเวสส, อุษา ฉายเกล็ดแก้ว, อดุลย์ โมฮารา, ชนิดา เลิศพิทักษ์พงศ์, อินทิรา ยมาภัย,.
วารสารวิชาการสาธารณสุข. 2011; 5(3): 307-316, 2011.

A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand

Leelahavarong P,Chaikledkaew U*, Hongeng S, Kasemsup V, Lubell Y, Teerawattananon Y..
BMC Health Services Research 2010; 10: Art. No. 209, 2010.

Budget impact of the thalassemia management under the national health security scheme in Thailand

Riewpaiboon A*, Bunyadharokul S, Chaikledkaew U, Torcharus K..
Mahidol J Pharm. Sci 2010; 37(1-2): 28-39., 2010.

The economic costs of alcohol consumption in Thailand, 2006

Thavorncharoensap M*, Teerawattananon Y, Yothasamut J, Lertpitakpong C, Thitiboonsuwan K, Neramitpitagkul P, Chaikledkaew U..
BMC Public Health 2010; 10: 323, 2010.

ปัจจัยที่มีผลต่อการเข้าถึงการผ่าตัดผ่านกล้องในประเทศไทย: ผลการวิเคราะห์ข้อมูลผู้ป่วยในระดับประเทศ ปี พ.ศ. 2548-2550

วชิรานี วงศ์ก้อม, คัคนางค์ ไชรศิริ, อุษา ฉายเกล็ดแก้ว, ยศ ตีระวัฒนานนท์.
วารสารมหาวิทยาลัยศรีนครินทรวิโรฒ (สาขาวิทยาศาสตร์และเทคโนโลยี) 2553; 2(Suppl.1): 95-105., 2010.

Assessing enforcement of policy on limiting alcohol accessibility and alcohol purchasing. ;

Lertpitakpong C, Teerawattananon Y, Thavorncharoensap M, Thitiboonsuwan K, Yothasamut J, Chaikledkaew U..
J Health Science 2009;18: 537-49., 2009.

Cost of productivity loss due to premature mortality related to alcohol drinking in Thailand.

Lertpitakpong C, Thavorncharoensap M, Neramitpitagkul P,Chaikledkaew U, Teerawattananon Y..
J Health Science 2009:18:3:322-332., 2009.

Economic impact on health care costs related to major diseases including HIV/AIDS due to alcohol drinking among Thai populations

Neramitpitagkul P, Lertpitakpong C, Yothasamut J, Thavorncharoensap M, Chaikledkaew U*, Teerawattananon Y..
Value Health 2009; 12(Sp.lss.2 Suppl.3): S97-S100., 2009.

Provider-initiated HIV/AIDS counseling and testing at healthcare facilities in Thailand: a cluster-randomisation trial

Teerawattananon Y, Leelukkanaveera Y, Thavorncharoensap M, Hanvoravongchai P, Ingsrisawang L, Tantives S, Chaikledkaew U, Mohara A, Lertpiriyasuwat C, Pimsawan N.
Journal of development effectiveness 2009:1(4):450-469., 2009.

The Economic impact of alcohol consumption: A systematic review

Thavorncharoensap M*, Teerawattananon Y, Yothasamut J, Lertpitakpong C, Chaikledkaew U..
Subst Abuse Treat Prev Policy 2009; 4: 20, 2009.

The current capacity and future development of economic evaluation for policy decision making: a survey among researchers and decision makers in Thailand

Chaikledkaew U*, Lertpitakpong C, Teerawattananon Y, Thavorncharoensap M, Tangcharoensathien V..
Value Health 2009; 12(Sp.Iss.2 Suppl.3): S31-S35., 2009.

ต้นทุนทางเศรษฐศาสตร์ของการขาดงานและด้อยประสิทธิภาพการทำงานจากการบริโภคแอลกอฮอล์

กรรณิการ์ ฐิติบุญสุวรรณ, มนทรัตม์ ถาวรเจริญทรัพย์, ชนิดา เลิศพิทักษ์พงษ์, จอมขวัญ โยธาสมุทร, อุษา ฉายเกล็ดแก้ว, ยศ ตีระวัฒนานนท์.
วารสารวิจัยระบบสาธารณสุข 2552; 3(1): 102-112, 2009.

A determination of topics for health technology assessment in Thailand: making decision makers involved

Lertpitakpong C, Chaikledkaew U, Thavorncharoensap M, Tantivess S, Praditsitthikorn N, Youngkogn S, Yothasamut J, Udomsuk K, Sinthitichai K, Teerawattananon Y.
J Med Assoc Thai 2008;91(Suppl 2):S100-9., 2008.

A drug cost model for injuries due to road traffic accidents

Riewpaiboon A, Piyauthakit P, Srijariya W, Chaikledkaew U.
Pharmacy Practice. 2008; 6(1) Jan: 9-14., 2008.

Economic burden of road traffic injuries: A micro-costing approach

Riewpaiboon A, Piyauthakit P, Chaikledkaew U.
Southeast Asia J Trop Med Public Health 2008; 39(6): 1139-1149., 2008.

Factors affecting health-care costs and hospitalizations among diabetic patients in Thai public hospitals

Chaikledkaew U*, Pongcharoensuk P, Chaiyakunapruk N, Ongphiphadhanakul B..
Value Health 2008; 11(Suppl.1): S69-S74. Mar, 2008.

Factors associated with healthcare costs and hospitalizations in patients with diabetes in Thai public hospitals.

Chaikledkaew U, Pongcharoensuk P, Chaiyakunapruk, Ongphiphadhanakul B. .
Value Health 2008; 2 (Suppl 1): S69-S74., 2008.

Making health technology assessment information available for decision making: the development of a Thai database.

Kapol N, Maitreemit P, Chalongsuk R, Amrumpai Y, Sribundit N, Thavorncharoensap M, Chaikledkaew U, Teerawattananon Y..
J Med Assoc Thai 2008;91(Suppl 2):S8-10, 2008.

Presentation of economic evaluation results

Chaikledkaew U*, Teerawattananon Y..
J Med Assoc Thai 2008; 91 Suppl 2: S66-73, 2008.

System dynamic modeling: An alternative method for budgeting

Srijariya W, Riewpaiboon A, Chaikledkaew U..
Value Health 2008; 11(Suppl.1): S115-S123. Mar, 2008.

การคัดเลือกหัวข้อสำหรับการประเมินเทคโนโลยีและนโยบายด้านสุขภาพในประเทศ: กรณีศึกษาการมีส่วนร่วมโดยผู้กำหนดนโยบาย

ชนิดา เลิศพิทักษ์พงศ์, อุษา ฉายเกล็ดแก้ว, มนทรัตม์ ถาวรเจริญทรัพย์, ศรีเพ็ญ ตันติเวสส, นัยนา ประดิษฐ์สิทธิกร, ศิตาพร ยังคง, จอมขวัญ โยธาสมุทร, กาญจนาถ อุดมสุข, กงกช สินธิติชัย, ยศ ตีระวัฒนานนท์.
วารสารวิชาการสาธารณสุข 2551;17(4), 2008.

Factors associated with healthcare cost saving in patients with diabetes to the California Medicaid populations (Medi-Cal)

Chaikledkaew U, Johnson KA.
Value Health 2005; 8 (3): 314, 2005.

Factors associated with healthcare expenditures and hospitalizations in Thai patients with diabetes at four public hospitals.

Chaikledkaew U, Pongcharoensuk P, Ongphiphadhanakul B, Chaiyakunapruk N. .
Mahidol J Pharm Sci 2005; 32(1-2): 1-6., 2005.

The cost-effectiveness of donepezil and rivastigmine in the treatment of Alzheime

Pattanaprateep O, Phongcharoensuk P,Chaikledkaew U.
Value Health 2005; 8(3): 314, 2005.

Prevalence of Idiopathic Inflammatory Demyelinating Central Nervous System Disorder in Thailand

Prayoonwiwat N, Apiwattanakul M, Pasogpakdee P, Siritho S, Chanatittarat C, Chaikledkaew U..
Multiple sclerosis journal 2015; 21(6): 824-824, 2015.

Survival of Hepatocellular Carcinoma patients Receiving Transarterial Chemoembolization: Results from Systematic Reviews and Network Meta-Analysis

Maneeon S, Chaikledkaew U*..
The 5th national and International Graduate Study Conference 2015, July 16-17, 2015 at Princess maha Chakrit Sirindhon Anthropology Centre, Thailand 2015;, 2015.

The Quality of Life in Thai Patients with Neuromyelitis Optica Spectrum Disorders

Siritho S, Pasogpakdee P, Apiwattanakul M, Prayoonwiwat N, Chankrachang S, Chanatittarat C, Chaikledkaew U..
Multiple sclerosis journal 2015; 21(6): 825-826, 2015.

A cost-utility and budget impact analysis of drug treatments in pulmonary arterial hypertension assoclated with congenital heart diseases

Thongsri W, Bussabawalai Th, Leelahavarong P, Chaikledkaew U*, Durongpisitkul K, Wanikun S, Sopradeekul S, Tangcharoe T, Teerawattananon Y..
Pharma Indochina VIII ASEAN Pharmacy - Integration for Development, Vietnam. on 4 - 5 December 2013 , 2013.

An informal care cost of central nervous system inflammatory demyelinating disorder patients in thailand: a preliminary report

Chanatittarat C*, Prayoonwiwat N, Siritho S, Chaikledkaew U..
Pharma Indochina VIII ASEAN Pharmacy - Integration for Development, Vietnam. on 4 - 5 December 2013 , 2013.

Health related quality of life (HRQOL) in Thai diabetic patients.

Thavorncharoensap M., Pongcharoensuk P., Chaikledkaew U., Suksomboon N. .
the ISPOR 2nd Asia Pacific conference 5-7 March 2006, Shanghai,, 2009.

Is productivity loss due to road traffic injuries a hidden cost?

Riewpaiboon A, Piyauthakit P, Chaikledkaew U..
9th World Conference on Injury Prevention and Safety15 – 18 March 2008, Merida, Mexico, , 2008.

Costs of type 2 diabetes patients in Thai government hospitals in 2003

Pongcharoensuk P, Tantivipanuwong S, Kongsaktrakoon B, Sema-ngern K, Chaikledkaew U, Chaiyakunapruk N.
17th Annual Meeting, The Endocrine Society of Thailand 2005, September 22-23: 17, 2005.

The cost-effectiveness of donepezil and rivastigmine in the treatment of alzheimer’s disease in thailand private hospital

Pattanaprateep O, Phongchareonsuk P, Chaikledkaew U.
ISPOR 10th Annual International Meeting,. Washington D.C., USA. 2005, May 15-18, 2005.

Adherence Index : A new and improved method to calculate compliance and persistency

Chaikledkaew U, Marks AS.
9th Annual International Meeting, International Society of Pharmacoeconomics and Outcomes Research (ISPOR), Crystal City 2004, May 18-21, 2004.